trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Nerve Degeneration D009410 53 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Cytomegalovirus Infections D003586 7 associated lipids
Nasal Polyps D009298 26 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Mast-Cell Sarcoma D012515 9 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Wang W et al. The acetylation of transcription factor HBP1 by p300/CBP enhances p16INK4A expression. 2012 Nucleic Acids Res. pmid:21967847
Lee TB et al. Histone H4 deacetylation down-regulates catalase gene expression in doxorubicin-resistant AML subline. 2012 Cell Biol. Toxicol. pmid:21968610
Rhodes LV et al. The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells. 2012 Oncol. Rep. pmid:21971930
Liu W et al. HDAC6 regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation in renal epithelial cells. 2012 PLoS ONE pmid:23152903
Hong X et al. Heparanase expression is associated with histone modifications in glioblastoma. 2012 Int. J. Oncol. pmid:22001963
Li Y et al. Impairment of p53 acetylation by EWS-Fli1 chimeric protein in Ewing family tumors. 2012 Cancer Lett. pmid:22266186
Bajbouj K et al. P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells. 2012 J. Neurooncol. pmid:22270849
Zhang L et al. Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis. 2012 J. Pharmacol. Exp. Ther. pmid:22271820
He D et al. Protocadherin8 is a functional tumor suppressor frequently inactivated by promoter methylation in nasopharyngeal carcinoma. 2012 Eur. J. Cancer Prev. pmid:22273848
Hosoya T et al. Trichostatin analogues JBIR-109, JBIR-110, and JBIR-111 from the marine sponge-derived Streptomyces sp. RM72. 2012 J. Nat. Prod. pmid:22276693
Baud MG et al. Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets. 2012 J. Med. Chem. pmid:22280363
Heller G et al. Genome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers. 2012 Clin. Cancer Res. pmid:22282464
Hirata Y et al. Anti-tumor activity of new orally bioavailable 2-amino-5-(thiophen-2-yl)benzamide-series histone deacetylase inhibitors, possessing an aqueous soluble functional group as a surface recognition domain. 2012 Bioorg. Med. Chem. Lett. pmid:22321215
Kan R et al. Potential role for PADI-mediated histone citrullination in preimplantation development. 2012 BMC Dev. Biol. pmid:22712504
To SQ et al. Epigenetic mechanisms regulate the prostaglandin E receptor 2 in breast cancer. 2012 J. Steroid Biochem. Mol. Biol. pmid:22929011
Liao V et al. Amide-based derivatives of β-alanine hydroxamic acid as histone deacetylase inhibitors: attenuation of potency through resonance effects. 2012 Bioorg. Med. Chem. Lett. pmid:22932316
Shan J et al. ATF4-dependent regulation of the JMJD3 gene during amino acid deprivation can be rescued in Atf4-deficient cells by inhibition of deacetylation. 2012 J. Biol. Chem. pmid:22955275
Sadoul K et al. HDAC6 controls the kinetics of platelet activation. 2012 Blood pmid:22955928
de Souza CF et al. Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis. 2012 PLoS ONE pmid:22984562
Otsuji TG et al. Dynamic link between histone H3 acetylation and an increase in the functional characteristics of human ESC/iPSC-derived cardiomyocytes. 2012 PLoS ONE pmid:22984602
Ma P et al. Compensatory functions of histone deacetylase 1 (HDAC1) and HDAC2 regulate transcription and apoptosis during mouse oocyte development. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22223663
Szablowska-Gadomska I et al. Treatment with small molecules is an important milestone towards the induction of pluripotency in neural stem cells derived from human cord blood. 2012 Acta Neurobiol Exp (Wars) pmid:23377265
Wang B et al. Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage. 2012 Free Radic. Biol. Med. pmid:22226832
Liu H et al. Inhibition of class II histone deacetylase blocks proliferation and promotes neuronal differentiation of the embryonic rat neural progenitor cells. 2012 Acta Neurobiol Exp (Wars) pmid:23377267
Tong K et al. Schizosaccharomyces pombe Hat1 (Kat1) is associated with Mis16 and is required for telomeric silencing. 2012 Eukaryotic Cell pmid:22771823
Zheng L et al. [Detecting acetylated proteins by affinity chromatography column]. 2012 Zhonghua Xue Ye Xue Za Zhi pmid:22781610
Yao J et al. ERK inhibition enhances TSA-induced gastric cancer cell apoptosis via NF-κB-dependent and Notch-independent mechanism. 2012 Life Sci. pmid:22781708
Cheng DD et al. Antitumor activity of histone deacetylase inhibitor trichostatin A in osteosarcoma cells. 2012 Asian Pac. J. Cancer Prev. pmid:22799338
Mostovich LA et al. The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer. 2012 Epigenetics pmid:22805760
Kadowaki M et al. DNA methylation-mediated silencing of nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) in glioma cell lines. 2012 Int. J. Cancer pmid:21437897
Zou Y et al. Effect of phenylhexyl isothiocyanate on aberrant histone H3 methylation in primary human acute leukemia. 2012 J Hematol Oncol pmid:22747680
Scholl C et al. Distinct and overlapping gene regulatory networks in BMP- and HDAC-controlled cell fate determination in the embryonic forebrain. 2012 BMC Genomics pmid:22748179
Bar-Nur O et al. Molecular analysis of FMR1 reactivation in fragile-X induced pluripotent stem cells and their neuronal derivatives. 2012 J Mol Cell Biol pmid:22430918
Jung N et al. Pharmacological unmasking microarray approach-based discovery of novel DNA methylation markers for hepatocellular carcinoma. 2012 J. Korean Med. Sci. pmid:22690089
Nunes MJ et al. Okadaic acid inhibits the trichostatin A-mediated increase of human CYP46A1 neuronal expression in a ERK1/2-Sp3-dependent pathway. 2012 J. Lipid Res. pmid:22693257
Kim Y et al. Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein. 2012 J. Biol. Chem. pmid:22679019
Xiong H et al. Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells. 2012 Mol. Carcinog. pmid:21520296
Zhu K et al. Expression characterization and the promoter activity analysis of zebrafish hdac4. 2012 Fish Physiol. Biochem. pmid:21773810
Qiao F et al. Enforced expression of RASAL1 suppresses cell proliferation and the transformation ability of gastric cancer cells. 2012 Oncol. Rep. pmid:22825043
Shao G et al. [Effect of monoamine oxidase inhibitor on the differentiation of malignant glioma cell]. 2012 Sheng Wu Yi Xue Gong Cheng Xue Za Zhi pmid:22826952
Yu J et al. Regulation of radiosensitivity by HDAC inhibitor trichostatin A in the human cervical carcinoma cell line Hela. 2012 Eur. J. Gynaecol. Oncol. pmid:22873101
Karolczak-Bayatti M et al. Expression of the GTP-binding protein Gαs in human myometrial cells is regulated by ubiquitination and protein degradation: involvement of proteasomal inhibition by trichostatin A. 2012 Reprod Sci pmid:22875848
Balaguer TM et al. Dual regulation of P-glycoprotein expression by trichostatin A in cancer cell lines. 2012 BMC Mol. Biol. pmid:22846052
Li L et al. Regulation of histone acetylation by NDRG2 in glioma cells. 2012 J. Neurooncol. pmid:21912936
Li L et al. Use of mouse hematopoietic stem and progenitor cells to treat acute kidney injury. 2012 Am. J. Physiol. Renal Physiol. pmid:21937606
Jee BC et al. Effect of trichostatin A on fertilization and embryo development during extended culture of mouse oocyte. 2012 Zygote pmid:21269543
Sustáčková G et al. Acetylation-dependent nuclear arrangement and recruitment of BMI1 protein to UV-damaged chromatin. 2012 J. Cell. Physiol. pmid:21732356
Dehnugara T et al. An in vitro, short-term culture method for mammalian haploid round spermatids amenable for molecular manipulation. 2012 Mol. Reprod. Dev. pmid:21953649
McCullough SD et al. Reelin is a target of polyglutamine expanded ataxin-7 in human spinocerebellar ataxia type 7 (SCA7) astrocytes. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:23236151
Xie BT et al. [Telomere lengthening by trichostatin A treatment in cloned pigs]. 2012 Yi Chuan pmid:23262106